Global Nattokinase Supplements Market Size, Share, and Trends Analysis Report, By Application (Hospitals, Institutions, Individuals, and Others) Forecast Period (2022-2028)

The global nattokinase supplements market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Nattokinase is an enzyme derived from natto, which is a Japanese condiment prepared from cooked soybeans that have been fermented with bacteria. Nattokinase thins the blood and aids in the breaking up of blood clots. This may help to prevent heart disease and other illnesses caused by blood clots, such as stroke and heart attack. The rising prevalence of cardiovascular illnesses such as heart disease, high blood pressure, high cholesterol, and stroke are driving the nattokinase supplements market.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance-

• In March 2021, Lifestream Group, a Singapore-based nutraceutical company, has added a vegan product to its VesseCLEAR cardiovascular supplement line, which is said to provide a broader spectrum of support for healthy aging. The first supplement, VesseCLEAR EX, was released in 2019 and comprises Nattokinase (NSK-SD40), which is derived from non-GMO soybeans fermented with Bacillus subtilis natto, as well as elastin F, a peptide derived from bonito fish. Additionally, The European Food Safety Authority has announced the publishing and acceptance of NSK-SD nattokinase as a novel food ingredient in the EU market. NSK-SD has received approval in all 28 EU member states and has been highlighted in the EU’s Office Journal. B. subtilis ferments boiling soybeans to generate NSK SD nattokinase, a powerful fibrinolytic enzyme. Natto, a traditional Japanese delicacy, is produced as a result of this process, and the enzyme is named for it. By digesting circulating fibrin, NSK SD nattokinase may assist in the normalization of blood viscosity and pressure.
• In August 2020, Umeken, one of the leading health food manufacturers based in Cerritos, California, and Osaka, Japan, has released three new products this summer to continue its commitment to high-quality supplements and a natural health care approach: a smaller size of the best-selling Nattokinase plus Fucoidan, an upgraded formula of the popular Corbicula Ball EX, and the all-new Lipopo-C. These more affordable and updated solutions have been made available so that people can continue to care for their health during the COVID-19 pandemic.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

• Competitive Landscape– Biovea, Boostceuticals, Swanson Health Products, Nutraceutical Corp., and Dynamic Nutrition, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Nattokinase Supplements Market Report by Segment

By Application

• Hospitals
• Institutions
• Individuals
• Others

Global Nattokinase Supplements Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa